In advance of adcomm, Pfizer makes its case for Comirnaty booster
Regulatory NewsKari Oakes
Biologics/ biosimilars/ vaccinesHealth Authority meeting and communication strategyNorth AmericaRegulatory Intelligence/PolicyRegulatory NewsKari OakesBiologics/ biosimilars/ vaccinesHealth Authority meeting and communication strategyNorth AmericaRegulatory Intelligence/Policy